Clinical trial
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure
NCT00520806 is registered in ClinicalTrials.gov with Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure
- Lead sponsor
- Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- September 30, 2012
- Enrollment
- 1,161 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, congestive